N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethy-l)phenyl]amino]-4-pyrimidinyl]amino]benz

Modify Date: 2024-02-03 08:04:42

N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethy-l)phenyl]amino]-4-pyrimidinyl]amino]benz structure	Common Name	N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethy-l)phenyl]amino]-4-pyrimidinyl]amino]benz
	CAS Number	936091-56-4	Molecular Weight	510.65
	Density	1.3±0.1 g/cm3	Boiling Point	686.9±65.0 °C at 760 mmHg
	Molecular Formula	C₂₆H₃₄N₆O₃S	Melting Point	N/A
	MSDS	N/A	Flash Point	369.3±34.3 °C

Use of N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethy-l)phenyl]amino]-4-pyrimidinyl]amino]benz

JAK-IN-32 (XC) is a bi-aryl meta-pyrimidine inhibitor of JAK kinase[1].

Name	N-tert-butyl-3-[[5-methyl-2-[3-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide
Synonym	More Synonyms

Description	JAK-IN-32 (XC) is a bi-aryl meta-pyrimidine inhibitor of JAK kinase[1].
Related Catalog	Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Research Areas >> Others
References	[1]. Glenn Noronha, et al. Bi-aryl meta-pyrimidine inhibitors of kinases. Patent. US20110212077A1.

Hazard Codes	Xi

3-[(5-Methyl-2-{[3-(4-morpholinylmethyl)phenyl]amino}-4-pyrimidinyl)amino]-N-(2-methyl-2-propanyl)benzenesulfonamide

Benzenesulfonamide, N-(1,1-dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]-

cc-107

EX-8666

RS0110

N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide

N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethy - l)phenyl]amino]-4-pyrimidinyl]amino]benz

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3